First to File Bioequivalency

Frontage assisted a Sponsor that required accelerated timelines in order to be the first to file a generic anti-epilepsy drug. As a result, the study required a high degree of upfront planning and coordination.

Thank you for registering!

You now have the option of downloading the resource or viewing the web version below.